S L Highlander

562 total citations
10 papers, 514 citations indexed

About

S L Highlander is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, S L Highlander has authored 10 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in S L Highlander's work include Herpesvirus Infections and Treatments (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). S L Highlander is often cited by papers focused on Herpesvirus Infections and Treatments (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). S L Highlander collaborates with scholars based in United States. S L Highlander's co-authors include Joseph C. Glorioso, Michael Levine, Philip J. Gage, David C. Johnson, Sheena Sutherland, S. Person, W Cai, T C Holland, Sandrine Marlin and Wu Chun and has published in prestigious journals such as Journal of Virology, Expert Opinion on Therapeutic Patents and Biotechnology Law Report.

In The Last Decade

S L Highlander

10 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S L Highlander United States	7	468	212	178	102	82	10	514
C J Heilman United States	10	478 1.0×	199 0.9×	149 0.8×	185 1.8×	72 0.9×	11	548
R.J. Eisenberg United States	8	536 1.1×	204 1.0×	194 1.1×	112 1.1×	88 1.1×	9	606
Manuel Ponce-de-León United States	9	351 0.8×	138 0.7×	115 0.6×	38 0.4×	108 1.3×	10	421
R J Frink United States	8	514 1.1×	159 0.8×	206 1.2×	124 1.2×	65 0.8×	8	570
M L Haffey Sweden	9	501 1.1×	177 0.8×	180 1.0×	86 0.8×	82 1.0×	13	600
Gary H. Cohen United States	7	354 0.8×	160 0.8×	126 0.7×	60 0.6×	56 0.7×	7	429
Marianne Gibson United States	6	189 0.4×	122 0.6×	198 1.1×	86 0.8×	35 0.4×	10	417
H. Moss Slovakia	10	504 1.1×	131 0.6×	162 0.9×	28 0.3×	99 1.2×	12	567
Cristina Forghieri Italy	5	375 0.8×	134 0.6×	142 0.8×	27 0.3×	54 0.7×	8	452
Chieko Kai Japan	14	319 0.7×	98 0.5×	105 0.6×	23 0.2×	103 1.3×	35	449

Countries citing papers authored by S L Highlander

Since Specialization

Citations

This map shows the geographic impact of S L Highlander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S L Highlander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S L Highlander more than expected).

Fields of papers citing papers by S L Highlander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S L Highlander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S L Highlander. The network helps show where S L Highlander may publish in the future.

Co-authorship network of co-authors of S L Highlander

This figure shows the co-authorship network connecting the top 25 collaborators of S L Highlander. A scholar is included among the top collaborators of S L Highlander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S L Highlander. S L Highlander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Highlander, S L, et al.. (2008). Patent strategies for therapeutic RNAi. Expert Opinion on Therapeutic Patents. 18(11). 1289–1298. 1 indexed citations

Highlander, S L, et al.. (1994). {BLR 1894} CAFC - In re Bell - In re Deuel - PTO. Biotechnology Law Report. 13(6). 783–785. 1 indexed citations

Highlander, S L. (1994). {BLR 1752} Board of Patent Appeals and Interferences - Ex Parte Deuel - Ex Parte Movva - In re Bell - USPTO. Biotechnology Law Report. 13(4). 469–478. 1 indexed citations

Highlander, S L, William F. Goins, S. Person, et al.. (1991). Oligomer formation of the gB glycoprotein of herpes simplex virus type 1. Journal of Virology. 65(8). 4275–4283. 29 indexed citations

Chun, Wu, Michael Levine, Fred L. Homa, S L Highlander, & Joseph C. Glorioso. (1990). Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants. Journal of Virology. 64(2). 856–863. 27 indexed citations

Highlander, S L, et al.. (1990). Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B. Journal of Virology. 64(11). 5277–5283. 18 indexed citations

Highlander, S L, Philip J. Gage, T C Holland, et al.. (1989). Identification of mar mutations in herpes simplex virus type 1 glycoprotein B which alter antigenic structure and function in virus penetration. Journal of Virology. 63(2). 730–738. 62 indexed citations

Highlander, S L, W Cai, S. Person, Michael Levine, & Joseph C. Glorioso. (1988). Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration. Journal of Virology. 62(6). 1881–1888. 108 indexed citations

Highlander, S L, Sheena Sutherland, Philip J. Gage, et al.. (1987). Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. Journal of Virology. 61(11). 3356–3364. 223 indexed citations

10.

Marlin, Sandrine, S L Highlander, T C Holland, Michael Levine, & Joseph C. Glorioso. (1986). Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production. Journal of Virology. 59(1). 142–153. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact